JP2021527700A5 - - Google Patents

Info

Publication number
JP2021527700A5
JP2021527700A5 JP2020571400A JP2020571400A JP2021527700A5 JP 2021527700 A5 JP2021527700 A5 JP 2021527700A5 JP 2020571400 A JP2020571400 A JP 2020571400A JP 2020571400 A JP2020571400 A JP 2020571400A JP 2021527700 A5 JP2021527700 A5 JP 2021527700A5
Authority
JP
Japan
Prior art keywords
protein
subunit
amino acid
charge
heterodimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020571400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527700A (ja
JP7439372B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/038451 external-priority patent/WO2019246508A1/en
Publication of JP2021527700A publication Critical patent/JP2021527700A/ja
Publication of JP2021527700A5 publication Critical patent/JP2021527700A5/ja
Priority to JP2023098823A priority Critical patent/JP7452932B2/ja
Application granted granted Critical
Publication of JP7439372B2 publication Critical patent/JP7439372B2/ja
Priority to JP2024032407A priority patent/JP2024057087A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020571400A 2018-06-21 2019-06-21 ヘテロ二量体タンパク質及びその使用 Active JP7439372B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023098823A JP7452932B2 (ja) 2018-06-21 2023-06-15 ヘテロ二量体タンパク質及びその使用
JP2024032407A JP2024057087A (ja) 2018-06-21 2024-03-04 ヘテロ二量体タンパク質及びその使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862688167P 2018-06-21 2018-06-21
US62/688,167 2018-06-21
US201862703248P 2018-07-25 2018-07-25
US62/703,248 2018-07-25
PCT/US2019/038451 WO2019246508A1 (en) 2018-06-21 2019-06-21 Heterodimeric proteins and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023098823A Division JP7452932B2 (ja) 2018-06-21 2023-06-15 ヘテロ二量体タンパク質及びその使用

Publications (3)

Publication Number Publication Date
JP2021527700A JP2021527700A (ja) 2021-10-14
JP2021527700A5 true JP2021527700A5 (cg-RX-API-DMAC7.html) 2022-06-28
JP7439372B2 JP7439372B2 (ja) 2024-02-28

Family

ID=68983045

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020571400A Active JP7439372B2 (ja) 2018-06-21 2019-06-21 ヘテロ二量体タンパク質及びその使用
JP2023098823A Active JP7452932B2 (ja) 2018-06-21 2023-06-15 ヘテロ二量体タンパク質及びその使用
JP2024032407A Pending JP2024057087A (ja) 2018-06-21 2024-03-04 ヘテロ二量体タンパク質及びその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023098823A Active JP7452932B2 (ja) 2018-06-21 2023-06-15 ヘテロ二量体タンパク質及びその使用
JP2024032407A Pending JP2024057087A (ja) 2018-06-21 2024-03-04 ヘテロ二量体タンパク質及びその使用

Country Status (10)

Country Link
US (3) US10995127B2 (cg-RX-API-DMAC7.html)
EP (1) EP3810172A4 (cg-RX-API-DMAC7.html)
JP (3) JP7439372B2 (cg-RX-API-DMAC7.html)
KR (1) KR20210025054A (cg-RX-API-DMAC7.html)
CN (1) CN112566650A (cg-RX-API-DMAC7.html)
AU (1) AU2019290192A1 (cg-RX-API-DMAC7.html)
BR (1) BR112020026112A2 (cg-RX-API-DMAC7.html)
CA (1) CA3103975A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020014031A (cg-RX-API-DMAC7.html)
WO (1) WO2019246508A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112566650A (zh) * 2018-06-21 2021-03-26 沙塔克实验室有限公司 异二聚体蛋白及其用途
WO2021041958A1 (en) * 2019-08-30 2021-03-04 Shattuck Labs. Inc. Chimeric proteins in autoimmunity
US20230226202A1 (en) * 2020-03-30 2023-07-20 Proviva Therapeutics (Hong Kong) Limited Il-2/il15 compositions and methods of use thereof
US12012441B2 (en) 2020-10-26 2024-06-18 Neptune Biosciences Llc Engineered human IL-21 cytokines and methods for using the same
KR20240007256A (ko) 2021-05-12 2024-01-16 어플라이드 바이오메디컬 사이언스 인스티튜트 이황화 결합된 결합 폴리펩타이드의 스크리닝 및 발현 방법
US20240262893A1 (en) 2021-05-12 2024-08-08 Applied Biomedical Science Institute Binding polypeptides against sars cov-2 and uses thereof
EP4511054A4 (en) * 2022-04-20 2026-07-22 Neptune Biosciences Llc ORTHOGONAL CYTOKINE/IL-21 RECEPTOR SYSTEMS
CN119546322A (zh) 2022-05-16 2025-02-28 恩科弗洛斯生物科学股份有限公司 血脑屏障易位肽和相关分子及其使用方法
WO2024019984A1 (en) * 2022-07-18 2024-01-25 Cargo Therapeutics, Inc. Cytokine receptor switch polypeptides and uses thereof
AU2023379740A1 (en) 2022-11-16 2025-05-29 Applied Biomedical Science Institute Fusion polypeptides and binding peptides and methods for producing and using same
WO2024123812A1 (en) 2022-12-05 2024-06-13 Shattuck Labs, Inc. Fusion proteins for the treatment of cardiometabolic diseases
WO2025133115A1 (en) * 2023-12-21 2025-06-26 Ose Immunotherapeutics Lipid-based nanoparticles comprising il-35
CN122555718A (zh) * 2023-12-27 2026-08-11 上海药明生物技术有限公司 重组il-27蛋白及其制备方法
CN117986386B (zh) * 2024-02-06 2024-11-29 康立泰生物医药(青岛)有限公司 重组人白细胞介素-35及其制备方法和应用
US12698309B2 (en) * 2024-08-01 2026-08-04 Twilight Bioscience, Inc. HERV-K (HML-2) Env analog fusion proteins for antigen specific immunotherapy and methods of use
WO2026093414A1 (en) * 2024-10-30 2026-05-07 Ose Immunotherapeutics Lipid-based nanoparticles comprising membrane il-35

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031480A1 (en) * 1994-05-18 1995-11-23 S.P.I. Synthetic Peptides Incorporated Heterodimer polypeptide immunogen carrier composition and method
IT1274350B (it) * 1994-12-06 1997-07-17 Angeletti P Ist Richerche Bio Antagonisti di interleuchina-6(il-6) che consistono di forme solubili del ricettore alfa di il-6, mutate nell'interfaccia che si lega a gp 130
AU706504B2 (en) 1996-02-20 1999-06-17 Merck Serono Sa Hybrid proteins which form heterodimers
ES2221717T3 (es) * 1997-12-08 2005-01-01 Emd Lexigen Research Center Corp. Proteinas de fusion heterodimeras utiles para inmunoterapia dirigida e inmunoestimulacion general.
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
WO2001010912A1 (en) * 1999-08-09 2001-02-15 Lexigen Pharmaceuticals Corp. Multiple cytokine-antibody complexes
AU2001290524A1 (en) * 2000-08-08 2002-02-18 Zymogenetics Inc. Soluble zcytor 11 cytokine receptors
EP1781708B1 (en) * 2004-07-09 2011-02-16 Variety Children's Hospital d/b/a/ Miami Children's Hospital Materials and methods for immune system stimulation
EP2072527A1 (en) * 2007-12-21 2009-06-24 Altonabiotec AG Fusion polypeptides comprising a SHBG dimerization component and uses thereof
CN102712696A (zh) * 2009-09-16 2012-10-03 弗·哈夫曼-拉罗切有限公司 包含卷曲螺旋和/或系链的蛋白质复合体及其用途
US20130089554A1 (en) 2009-12-29 2013-04-11 Emergent Product Development Seattle, Llc RON Binding Constructs and Methods of Use Thereof
WO2011119484A1 (en) * 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding
UY35148A (es) * 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
EP3587448B1 (en) * 2013-03-15 2021-05-19 Xencor, Inc. Heterodimeric proteins
US10017545B2 (en) * 2013-06-03 2018-07-10 University Of Maryland, College Park Compositions and vaccines comprising vesicles and methods of using the same
CA2957148A1 (en) 2014-09-17 2016-03-24 Genentech, Inc. Immunoconjugates comprising anti-her2 antibodies and pyrrolobenzodiazepines
CN104403004B (zh) * 2014-11-24 2017-10-13 苏州丁孚靶点生物技术有限公司 抗体‑干扰素异二聚体的制备和用途
SG11201707182WA (en) * 2015-03-05 2017-10-30 Hutchinson Fred Cancer Res Immunomodulatory fusion proteins and uses thereof
MX2018001208A (es) * 2015-07-26 2018-03-26 Molecular Templates Inc Moleculas con direccion a las celulas que comprenden efectores de la subunidad a de la toxina shiga y epitopos de celulas-t cd8+.
SG10201913573UA (en) * 2015-10-01 2020-03-30 Heat Biologics Inc Compositions and methods for adjoining type i and type ii extracellular domains as heterologous chimeric proteins
CN108367069B (zh) 2015-12-14 2022-08-23 宏观基因有限公司 对于pd-1和ctla-4具有免疫反应性的双特异性分子及其使用方法
US10906957B2 (en) * 2016-09-27 2021-02-02 Epicentrx, Inc. Immunomodulatory fusion proteins
US12447213B2 (en) * 2016-10-07 2025-10-21 The Broad Institute, Inc. Modulation of novel immune checkpoint targets
IL268198B2 (en) * 2017-02-27 2024-10-01 Shattuck Labs Inc Tigit- and light-based chimeric proteins
CN112566650A (zh) * 2018-06-21 2021-03-26 沙塔克实验室有限公司 异二聚体蛋白及其用途
BR112021013193A2 (pt) * 2019-01-07 2021-09-28 Shattuck Labs, Inc. Proteínas heterodiméricas para modulação de células t gama delta
WO2021041958A1 (en) * 2019-08-30 2021-03-04 Shattuck Labs. Inc. Chimeric proteins in autoimmunity

Similar Documents

Publication Publication Date Title
JP6853317B2 (ja) 高度に低下された受容体結合親和性を有するサイトカインを含むフソカイン
US20220112260A1 (en) Molecules that selectively activate regulatory t cells for the treatment of autoimmune diseases
US7666622B2 (en) Monomeric self-associating fusion polypeptides and therapeutic uses thereof
JP2022058337A (ja) 自己免疫疾患の治療のために制御性t細胞を選択的に活性化する分子
US20220275048A1 (en) Dimer immunoadhesin, pharmaceutical compostion and use thereof
JP7814759B2 (ja) 二重特異性組換えタンパク質及びその使用
CN110437339A (zh) 一种以白介素15为活性成分的融合蛋白型药物前体
JP2024521405A5 (cg-RX-API-DMAC7.html)
JPH08507676A (ja) 可溶性オリゴマー蛋白質の調製法
RS55609B1 (sr) Fc fuzioni proteini koji sadrže nove linkere ili aranžmane
EP4019536A1 (en) Immunocytokine, preparation for same, and uses thereof
CN117500824A (zh) 包含IL-10或TGF-β激动剂多肽的嵌合分子
CN113518823A (zh) 多功能的融合蛋白及其用途
CA3149583A1 (en) Chimeric proteins in autoimmunity
CN112996819B (zh) 细胞分选系统及使用方法
JP7796754B2 (ja) インターロイキン-2ムテイン及びその使用
CN117561280A (zh) 携带TGF-β的抗原呈递多肽复合物及其使用方法
CA3180251A1 (en) Cytokine conjugates
Zhan et al. Fusion of HSA influences TNF-α neutralizing activity of shTNFRs
US20250115657A1 (en) Bispecific FC Fusion Proteins with sPD-1 and IL-15
CN116375880A (zh) 融合蛋白及其制备方法和应用
US11555060B2 (en) QTY FC fusion water soluble receptor proteins
WO2026036390A1 (zh) 白介素12突变体及其用途
HK40060282A (en) Multi-functional fusion proteins and uses thereof